We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Automatic Data Processing
ADP
$106B
| $91.4M | 0.21% |
435,076
+46,500
| +12% | +$10.2M |
|
102
Ovintiv
OVV
$17.3B
| $90.6M | 0.21% |
2,049,949
+408,743
| +25% | +$21.1M |
|
103
Norfolk Southern
NSC
$75.4B
| $90.3M | 0.21% |
397,306
+3,951
| +1% | +$970K |
|
104
Prologis
PLD
$135B
| $89.9M | 0.21% |
763,909
-8,820
| -1% | -$1.22M |
|
105
Healthcare Realty
HR
$7.28B
| $89.3M | 0.2% |
3,198,825
+2,641,827
| +474% | +$78.5M |
|
106
Boston Scientific
BSX
$69.5B
| $89M | 0.2% |
2,388,816
+400,800
| +20% | +$16.3M |
|
107
Cigna
CI
$73.7B
| $87.1M | 0.2% |
330,398
-6,800
| -2% | -$1.75M |
|
108
Deere & Co
DE
$160B
| $87.1M | 0.2% |
290,709
+97,800
| +51% | +$36M |
|
109
PayPal
PYPL
$48.9B
| $84.2M | 0.19% |
1,206,075
+139,500
| +13% | +$12.1M |
|
110
Citigroup
C
$222B
| $83.8M | 0.19% |
1,821,086
-124,800
| -6% | -$6.24M |
|
111
Motorola Solutions
MSI
$72.3B
| $83.7M | 0.19% |
399,264
+87,900
| +28% | +$19.2M |
|
112
Boeing
BA
$171B
| $82.6M | 0.19% |
604,158
+31,900
| +6% | +$4.71M |
|
113
DuPont de Nemours
DD
$18.5B
| $81.2M | 0.19% |
1,164,390
+307,186
| +36% | +$25.1M |
|
114
Lightspeed Commerce
LSPD
$1.31B
| $80.7M | 0.18% |
3,617,126
+983,882
| +37% | +$23.2M |
|
115
Carrier Global
CARR
$51B
| $80.3M | 0.18% |
2,252,632
+615,100
| +38% | +$24.1M |
|
116
Chubb
CB
$135B
| $79.9M | 0.18% |
406,283
-518,500
| -56% | -$107M |
|
117
Micron Technology
MU
$930B
| $79.1M | 0.18% |
1,431,130
+61,100
| +4% | +$4.15M |
|
118
Altria Group
MO
$114B
| $78.8M | 0.18% |
1,885,632
-18,200
| -1% | -$942K |
|
119
Honeywell
HON
$77B
| $78.7M | 0.18% |
480,588
-355,536
| -43% | -$63.8M |
|
120
KeyCorp
KEY
$24.2B
| $77M | 0.18% |
4,471,169
+3,821,100
| +588% | +$73.9M |
|
121
Bristol-Myers Squibb
BMY
$133B
| $76.8M | 0.18% |
997,060
+430,260
| +76% | +$32.8M |
|
122
CME Group
CME
$96.3B
| $76.6M | 0.18% |
374,331
-1,000
| -0.3% | -$212K |
|
123
Netflix
NFLX
$299B
| $76.5M | 0.18% |
4,377,330
-259,000
| -6% | -$5.74M |
|
124
Crown Castle
CCI
$33.3B
| $75.9M | 0.17% |
450,960
-400
| -0.1% | -$72.8K |
|
125
Booz Allen Hamilton
BAH
$8.39B
| $75.6M | 0.17% |
+837,064
| New | +$71.5M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.